Examining protein changes in peripheral blood cells just 24 hours after initiating chemotherapy for acute myeloid leukemia (AML) could predict 5-year overall survival, potentially allowing treatment ...
Panelists stress that timely and accurate diagnosis of KMT2A-rearranged acute myeloid leukemia (AML) is essential for personalized treatment planning, highlighting the need to overcome systemic delays ...
New research out of VCU Massey Comprehensive Cancer Center has uncovered a targeted cancer therapy that significantly ...
A simple blood test capable of detecting trace levels of leukaemia cells remaining after intensive chemotherapy has been developed by scientists at the National Institute for Health Research (NIHR) ...
A highly sensitive bone marrow test could double survival rates for some groups of younger adults with Acute Myeloid Leukaemia (AML) by helping doctors identify if they might relapse up to three ...
A 51-year-old woman from Wimbledon, England, says testing positive for leukemia actually saved her life—thanks to a new bone marrow test being studied in a clinical trial. Jan Leahy, a business ...
Acute myeloid leukemia (AML) is not hereditary, but a person may inherit gene mutations that make the condition more likely. Having a close family member with AML can also increase the risk. Acute ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results